RAPT Therapeutics (RAPT) Poised for Massive Breakout After Reverse Split and Clinical Wins
RAPT Therapeutics, Inc. (NASDAQ:RAPT) is a clinical-stage biopharmaceutical company at the forefront of precision immunology, developing oral small…
Could Seres Therapeutics (MRCB) Replace Antibiotics? This Biotech’s Next Drug Could Do It
Seres Therapeutics (MRCB), based in Cambridge, Massachusetts, stands at the vanguard of the live biotherapeutics revolution. Since its…
GlucoTrack (GCTK)’s Implant Could Kill Finger-Prick Testing Forever—Investors are Starting to Notice
GlucoTrack Inc. (NASDAQ:GCTK) is a pioneering medical technology company that has spent over two decades innovating diabetes management…
Sarepta Therapeutics (SRPT) May Be the Next $200 Biotech Stock Wall Street is Watching
Founded in 1980 and headquartered in Cambridge, Massachusetts, Sarepta Therapeutics Inc. (NASDAQ:SRPT) is a cutting-edge biotechnology company at…
Wall Street is Turning Bullish on Salarius Pharmaceuticals (SLRX)
Salarius Pharmaceuticals Inc. (NASDAQ:SLRX) is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for patients suffering from…
Conduit Pharmaceuticals (CDT) Could Deliver Massive Gains
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) is a clinical-stage biopharmaceutical company that is transforming the traditional model of drug development…
Could Lixte Biotechnology (LIXT) Turn a $1 Stock into a Multi-Bagger in 2025?
Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a pioneering clinical-stage pharmaceutical company focused on unlocking new frontiers in oncology…
Alzamend Neuro (ALZN) Could Be the Next 10x Biotech Breakout in 2025
Alzamend Neuro Inc. (NASDAQ:ALZN) is a forward-thinking clinical-stage biopharmaceutical company on a mission to revolutionize the treatment landscape…
Wall Street Forgot About Teladoc (TDOC)—Here’s Why That Could Be a Huge Mistake
Teladoc Health, Inc. (NYSE: TDOC) is a global pioneer in virtual healthcare, transforming how individuals access medical, mental…
Cidara Therapeutics (CDTX) Surges After Breakthrough Flu Trial—Is This the Future of Seasonal Protection?
Cidara Therapeutics, Inc. (NASDAQ:CDTX) is a San Diego-based, clinical-stage biotechnology company at the forefront of a new class…
Cullgen Merger Could Make Pulmatrix (PULM) a Biotech Dark Horse
Pulmatrix Inc. (NASDAQ:PULM) is a U.S.-based clinical-stage biopharmaceutical company that has carved a unique niche in the biotech…
Capricor (CAPR) Emerges as a Top Buyout Target After Breakthrough Duchenne Data
Capricor Therapeutics Inc. (NASDAQ:CAPR) is a late-stage biotechnology company at the forefront of developing transformative cell and exosome-based…
CorMedix (CRMD) Just Posted Its 1st Profit—Is This Biotech Rocket About to Launch?
CorMedix Inc. (NASDAQ: CRMD) is a commercial-stage biopharmaceutical company that has reached a rare inflection point for small-cap…
Scinai (SCNI) Jumps 29%—Biotech Investors Are Betting on Scinai’s Dual-Revenue Model
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) is an emerging biopharmaceutical company that operates at the intersection of cutting-edge immunology research…
Protagenic (PTIX) Explodes 300% After Merger With Phytanix—Is This the Next Biotech Breakout?
Protagenic Therapeutics, Inc. (NASDAQ: PTIX) has long focused on the development of peptide-based therapeutics aimed at treating stress-related…
Windtree Therapeutics (WINT)’s Big Comeback: Will it be the Next Biotech Superstar?
Windtree Therapeutics Inc. (NASDAQ:WINT) is a clinical-stage biotechnology company at the forefront of innovation in cardiovascular medicine and…
Wall Street Isn’t Paying Attention to Revelation Bio (REVB)… Yet.
Revelation Biosciences Inc. (NASDAQ:REVB) is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to transforming the…
Shuttle Pharma (SHPH) is Set to Explode: Here’s Why
Shuttle Pharmaceuticals Holdings Inc. (NASDAQ:SHPH) is a clinical-stage specialty pharmaceutical company pioneering a novel approach to cancer treatment…